TAXA Biotechnologies, Inc

TAXA Biotechnologies, Inc logo via Clearbit

Profile

According to their SEC filings, TAXA Biotechnologies, Inc is a Corporation organized in DE on 03-08-2012. They report having 3 employee(s), and revenue in their most-recent fiscal year of $3,892.00 and $5,694.00 the prior year.

Location

665 3rd Street

Ste 230

San Francisco, CA 94107

Equity Crowdfunding Campaigns

Reg CF Offering from TAXA Biotechnologies Inc (Previous)

Campaign Details

According to their SEC filings, TAXA Biotechnologies Inc previously ran a Regulation Crowdfunding campaign to raise $0.00 (up to a maximum of $0.00) in via before a deadline of .

As compensation for managing the offering, reported being compensated as follows:

In addition to any direct compensation, TAXA Biotechnologies Inc reported that would also receive the following financial interest in the offering:

TAXA Biotechnologies Inc filed the following progress report with the SEC at the end of their campaign:

The final number is $309,807.00 in investments. The deadline date was set to today to work around an EDGAR glitch but the offering actually closed on 08-09-16.

More information about this issuer may also be available via Crowditz.com, including information about weekly and aggregate investor commitments.

Financial Information

The following information is taken directly from SEC filings.

Income Statement Items

Most Recent Fiscal Year Prior Fiscal Year
Revenue $3,892.00 $5,694.00
Cost of Goods Sold $0.00 $0.00
Taxes Paid $1,457.00 $1,247.00
Net Income $-366,880.00 $-298,573.00

Balance Sheet Items

Most Recent Fiscal Year Prior Fiscal Year
Total Assets $0.00 $0.00
Cash and Cash Equivalents $182,977.00 $193,376.00
Accounts Receivable $0.00 $1,097.00
Short-term Debt $581,161.00 $589,120.00
Long-term Debt $732,807.00 $423,000.00

Complete Reg CF filings list for TAXA Biotechnologies, Inc

  • [2017-05-01T19:28:07+00:00] TAXA Biotechnologies, Inc filed a Form C-AR.

    File number: 020-22819

  • [2016-11-22T19:36:27+00:00] TAXA Biotechnologies, Inc filed a fundraising progress report (Form C-U) with the following update: "The final number is $309,807.00 in investments. The deadline date was set to today to work around an EDGAR glitch but the offering actually closed on 08-09-16."

    File number: 020-22819

  • [2016-08-18T14:12:07+00:00] TAXA Biotechnologies, Inc filed a fundraising progress report (Form C-U) with the following update: "The final number is $309,807.00 in investments. The deadline date was set to today to work around an EDGAR glitch but the offering actually closed on 08-09-16."

    File number: 020-22819

  • [2016-08-02T16:24:38+00:00] TAXA Biotechnologies, Inc filed an amended Form C (Form C/A) regarding their offering to raise a target of $200,000.00 via Wefunder. The nature of the amendment was described as follows:

    Changed deadline date, updated Form C, updated business plan and included transcription of the podcast.

    File number: 020-22819

  • [2016-06-01T17:11:50+00:00] TAXA Biotechnologies, Inc filed an amended Form C (Form C/A) regarding their offering to raise a target of $200,000.00 via Wefunder. The nature of the amendment was described as follows:

    Include updated SAFE contract where major investor threshold is $10K instead of $25K.

    File number: 020-22819

  • [2016-06-01T10:11:40+00:00] TAXA Biotechnologies, Inc filed an amended Form C (Form C/A) regarding their offering to raise a target of $200,000.00 via Wefunder. The nature of the amendment was described as follows:

    Lowered target offering amount to $200K, include revenue share for the first $200K, and updated business plan.

    File number: 020-22819

  • New Filing Form C

    [2016-05-16T07:18:54+00:00] TAXA Biotechnologies, Inc filed a Form C to raise a target amount of $400,000.00 (up to a maximum of $1,000,000.00) of via Wefunder.

    File number: 020-22819